nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—AGTR2—focal segmental glomerulosclerosis	0.673	0.743	CbGaD
Tasosartan—AGTR1—focal segmental glomerulosclerosis	0.233	0.257	CbGaD
Tasosartan—AGTR1—nephron—focal segmental glomerulosclerosis	0.0122	0.336	CbGeAlD
Tasosartan—AGTR2—kidney—focal segmental glomerulosclerosis	0.0103	0.284	CbGeAlD
Tasosartan—AGTR2—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.00698	0.136	CbGpPWpGaD
Tasosartan—AGTR2—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.00629	0.123	CbGpPWpGaD
Tasosartan—AGTR1—endothelium—focal segmental glomerulosclerosis	0.00575	0.158	CbGeAlD
Tasosartan—AGTR2—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.00443	0.0865	CbGpPWpGaD
Tasosartan—AGTR1—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.00267	0.0521	CbGpPWpGaD
Tasosartan—AGTR1—nephron tubule—focal segmental glomerulosclerosis	0.00264	0.0725	CbGeAlD
Tasosartan—AGTR1—kidney—focal segmental glomerulosclerosis	0.00232	0.0637	CbGeAlD
Tasosartan—AGTR1—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.00227	0.0445	CbGpPWpGaD
Tasosartan—AGTR1—cortex of kidney—focal segmental glomerulosclerosis	0.00226	0.062	CbGeAlD
Tasosartan—AGTR2—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.00215	0.042	CbGpPWpGaD
Tasosartan—AGTR2—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.00194	0.0379	CbGpPWpGaD
Tasosartan—Azilsartan medoxomil—AGTR1—focal segmental glomerulosclerosis	0.00162	0.239	CrCbGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—focal segmental glomerulosclerosis	0.00158	0.0308	CbGpPWpGaD
Tasosartan—Forasartan—AGTR1—focal segmental glomerulosclerosis	0.0015	0.222	CrCbGaD
Tasosartan—AGTR1—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.00144	0.0282	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 signaling events—GNAQ—focal segmental glomerulosclerosis	0.00126	0.0246	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.000912	0.0178	CbGpPWpGaD
Tasosartan—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000851	0.0234	CbGeAlD
Tasosartan—AGTR1—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.000822	0.0161	CbGpPWpGaD
Tasosartan—Valsartan—AGTR1—focal segmental glomerulosclerosis	0.000789	0.117	CrCbGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000773	0.0151	CbGpPWpGaD
Tasosartan—Olmesartan—AGTR1—focal segmental glomerulosclerosis	0.000769	0.114	CrCbGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000714	0.014	CbGpPWpGaD
Tasosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.0007	0.0137	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000642	0.0125	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000612	0.012	CbGpPWpGaD
Tasosartan—Irbesartan—AGTR1—focal segmental glomerulosclerosis	0.000598	0.0885	CrCbGaD
Tasosartan—Candesartan—AGTR1—focal segmental glomerulosclerosis	0.000598	0.0885	CrCbGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—focal segmental glomerulosclerosis	0.000562	0.011	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000541	0.0106	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000519	0.0101	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000502	0.00982	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—focal segmental glomerulosclerosis	0.000477	0.00932	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000466	0.0091	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00043	0.00841	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000395	0.00772	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.000394	0.00769	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.000386	0.00755	CbGpPWpGaD
Tasosartan—Losartan—AGTR1—focal segmental glomerulosclerosis	0.000385	0.057	CrCbGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000352	0.00688	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000344	0.00673	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.000329	0.00643	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000328	0.00641	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000323	0.00632	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000313	0.00611	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000303	0.00591	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000297	0.00581	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000294	0.00575	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000288	0.00562	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000263	0.00514	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000261	0.00511	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000259	0.00507	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.000255	0.00499	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000252	0.00492	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000251	0.00491	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000239	0.00467	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000228	0.00446	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000223	0.00436	CbGpPWpGaD
Tasosartan—Losartan—ACE—focal segmental glomerulosclerosis	0.000223	0.033	CrCbGaD
Tasosartan—AGTR1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.000212	0.00414	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000209	0.00409	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.000205	0.004	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000203	0.00396	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000197	0.00386	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000189	0.0037	CbGpPWpGaD
Tasosartan—Valsartan—ALB—focal segmental glomerulosclerosis	0.000187	0.0276	CrCbGaD
Tasosartan—AGTR2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000185	0.00362	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000185	0.00361	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000169	0.0033	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000168	0.00329	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000154	0.00302	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000141	0.00276	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00014	0.00274	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000129	0.00251	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00012	0.00234	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000116	0.00227	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000112	0.00219	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000112	0.00218	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00011	0.00215	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000107	0.00209	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000105	0.00206	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000102	0.00199	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000101	0.00198	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.94e-05	0.00194	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	9.69e-05	0.00189	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	9.38e-05	0.00183	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.18e-05	0.00179	CbGpPWpGaD
Tasosartan—Losartan—ALB—focal segmental glomerulosclerosis	9.13e-05	0.0135	CrCbGaD
Tasosartan—AGTR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	8.52e-05	0.00166	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	8.18e-05	0.0016	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.64e-05	0.00149	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	7.27e-05	0.00142	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.6e-05	0.00129	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.04e-05	0.00118	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.02e-05	0.00118	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.98e-05	0.00117	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.85e-05	0.00114	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.48e-05	0.00107	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.03e-05	0.000983	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.82e-05	0.000943	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.9e-05	0.000762	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.78e-05	0.00074	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.58e-05	0.000701	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.24e-05	0.000633	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.99e-05	0.000585	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.49e-05	0.000487	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.91e-05	0.000373	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.57e-05	0.000307	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.34e-05	0.000262	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.18e-05	0.000231	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.09e-05	0.000213	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	8.18e-06	0.00016	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	7e-06	0.000137	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	5.37e-06	0.000105	CbGpPWpGaD
